“A University of Pennsylvania research team has defined a possible new way to fight a disease that is currently treatable only with the most expensive drug available for sale in the United States. In a study published this month in Blood, the Penn team describes the strategy, based on the oldest part of the human immune system – called “complement” — that could turn out to be less costly and more effective for the majority of patients with a rare blood disorder.”
To read entire press release: www.uphs.upenn.edu